
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies is an undervalued company in the orthopedic implant industry with potential for long-term growth through differentiated technology and partnerships. Recently, the company has seen increased gross profit, FDA clearance for a new product, and a focus on expanding into other healthcare markets. Despite risks such as competition and slow adoption, their strong management team and strategic transformation make them a promising investment opportunity.
Bears say
SINTX Technologies is a leader in the development, manufacturing, and commercialization of silicon nitride, which has emerged as a differentiated biomaterial in orthopedic and surgical medicine. Despite its potential, the company faces challenges in gaining adoption of its products due to barriers related to clinical evidence, familiarity, and purchasing dynamics, as well as competition from traditional materials. Additionally, the company's reliance on specialized manufacturing processes and partnerships for commercialization present risks to its future growth and profitability. While SINTX has a track record of success and a strong scientific foundation, the pace of adoption and reimbursement decisions will be important factors to watch in the company's future performance.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares